Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modificati⦠read more
Healthcare
Medical Devices
25 years
USD
Exclusive to Premium users
$37.46
Price-0.48%
-$0.18
$535.588m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$121.575m
-
1y CAGR-
3y CAGR-
5y CAGR-$19.863m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.39
-
1y CAGR-
3y CAGR-
5y CAGR$110.246m
$163.214m
Assets$52.968m
Liabilities$32.808m
Debt20.1%
-5.7x
Debt to EBITDA-$7.442m
-
1y CAGR-
3y CAGR-
5y CAGR